Navigation Links
New prostate cancer research findings
Date:10/4/2007

WHAT: The 2007 Prostate Cancer Foundation Scientific Retreat will feature new studies by the worlds leading researchers in prostate cancer. Presentations include discoveries expected to lead to new diagnostics and treatments, and the potential to help men avoid developing prostate cancer.

SELECTED PANELS INCLUDE:

  • Lifestyle Navigation: Researchers will share new research on how eating common foods such as tomatoes and fish, maintaining a healthy weight, and avoiding meats cooked at high temperatures may help prevent prostate cancer, and help men live healthier and longer after diagnosis. More widespread studies, in combination with newer technologies in gene research, are substantiating some long-held hypotheses
    (Embargoed until 1:00pm EDT Saturday, October 13th)
  • Epigenetics: Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
    (Embargoed until 11:15pm EDT Thursday, October 11th)
  • Intracrine androgens: Cancer researchers have long worked to understand why some prostate cancers recur after the use of therapies designed to stop the production of testosterone and other androgens that fuel cancer cell growth. New research has now detected that androgen-synthesizing proteins are present within cancer cells, which suggests that cancer cells may develop the capacity to produce their own androgens. The presence of these proteins may explain why some prostate cancers become resistant to these widely-used therapies, and offers new directions for research into treatments to block the development of these androgens in cancer cells.
    (Embargoed until 6:00pm EDT October 11th)

WHO: The Prostate Cancer Foun
'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
GYMR
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mitochondrial DNA mutations play significant role in prostate cancer
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
5. Test for early detection of prostate cancer shows promise
6. U-M researchers identify new blood test for prostate cancer
7. U-M scientists say fused genes trigger the development of prostate cancer
8. Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors
9. Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer
10. Virus chip detects new virus in prostate tumors
11. Human prostate grown from embryonic stem cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RK (November 24, 2009) -- The Wildlife Conservatio... that the last remaining population of Siberian ti...rising tide of poaching and habitat loss. , ...an officials of what needs to be done to protect r..., The report was released by the Sib...
(Date:11/23/2009)... presents strong evidence that the "synergistic" e...ic-related pollution and indoor endotoxin causes m... exposure alone. , Environmental health scient...of Medicine have shown that children exposed to bo...door endotoxin during early life are six times mor...
(Date:11/23/2009)... than 160 participants gathered this week for the ...TIATIVE conference. This year,s topic, "Synthetic ...and medical researchers to explore the engineering...erging field of synthetic biology. , Bonnie L. B...n University and this year,s conference chair, cha...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 1Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 3Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 4Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 5KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 1KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 2KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 3E Cigarettes Pose a Health Hazard FDA Warns 52474 1E Cigarettes Pose a Health Hazard FDA Warns 52474 2E Cigarettes Pose a Health Hazard FDA Warns 52474 3
...rs at the UC Davis M.I.N.D. Institute has found th... children born in California with autism since 199... condition is diagnosed or counted and the trend ...ary 2009 issue of the journal Epidemiology , resu...ld shift from genetics to the host of chemicals an...
...nal that publishes original research contributions... of entomology, plant pathology, virology, nematol...gicides, herbicides and other biocides. Emphasis ...iseases. , Phytoparasitica also publishes invit...t editorials written by reputable scientists attes...
... Prevention Research , a journal of the American A...nts of black raspberries with chemopreventive pote...ive Cancer Center found that anthocyanins, a class...wth and stimulated apoptosis in the esophagus of r...r data provide strong evidence that anthocyanins a...
Other Biology News:Study shows California's autism increase not due to better counting, diagnosis 2Study shows California's autism increase not due to better counting, diagnosis 3Springer expands its portfolio in plant sciences with Phytoparasitica 2
(Date:11/24/2009)...re-FirstCall/--Sigma-AldrichCorporation(Nasdaq: SI...day,December1stat1:45PMGMTinLondon,7:45AMUS/CST.In...heInternetavailableat http://inve s tor.sig m ...toaccessthisfile. ,, AboutSigma-Aldrich: Sig...mpany.Itschemicalandbiochemicalproductsandkitsareu...
(Date:11/24/2009)...RNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ...ommercializingnovelpainmanagementtherapies,announc...veOfficer,isscheduledtopresentatthe21stAnnualPiper...09atTheNewYorkPalaceHotelinNewYork,NewYork. ,, ...r,willbeavailabletorespondtoquestionsduringthepres...
(Date:11/24/2009)...asbeenmetforpatientswithadvanced-stage,orrecurrent...wire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;...panyfocusedonendocrinetherapyandoncology,todayanno...rgetedcytotoxicpeptideconjugate,AEZS-108(formerlyA...lcancer.Inapersonalizedhealthcareapproach,thestudy...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq...,sExecutiveChairman,willpresentatthe21stAnnualPipe...,December1,2009at10:00a.m.ET. ,, Toaccesstheliv...isittheInvestorRelationssectionofGenomicHealth,swe...onnecttothewebsiteatleast15minutespriortothebeginn...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...FRANCISCO, March 12 VIA Pharmaceuticals, Inc. (Na... the development of compounds for the treatment of...nced it has entered into a $10.0 million secured n...llary agreements, the "Loan Agreement") with Bay C...s (collectively, "Lender"), the Company,s principa...
... A significant challenge utili... the cost and uncertainty associated with vectors ...roblem, DNA2.0 has developed a new family of vecto...s. pJexpress vectors are specifically engineered t...own to express better than comparable pET vectors....
...ADELPHIA, March 12 ERT, a leading provider of cen...ther services to the biopharmaceutical, medical de... it will be showcasing its portfolio of products a... DIA Euromeeting, 23-25 March 2009 in Berlin, Germ...ing sessions, which will discuss the impact of tec...
Other Biology Technology:VIA Pharmaceuticals Secures Financing Up to $10.0 Million 2VIA Pharmaceuticals Secures Financing Up to $10.0 Million 3VIA Pharmaceuticals Secures Financing Up to $10.0 Million 4DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 2DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 3ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 3
Uniblot accessories from Sigma-Aldrich
StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
Aquarius 384 Multichannel Pipettor from Tecan
...nx software, a multitasking application capable of...amming and operation of lab automation workcells e...tom modification by programmers. • Users cr...wchart. If you can build a flowchart, you can writ...
Biology Products: